Search research articles
Contact Us
Filters
Showing results (11-20 of 28) with videos related to
Page
of 3
Sort By:
Oncotarget
|
January 30, 2016
Delivery of improved oncolytic adenoviruses by mesenchymal stromal cells for elimination of tumorigenic pancreatic cancer cells
Adam Kaczorowski, Katharina Hammer, Li Liu, et al.
Diagnostics (Basel, Switzerland)
|
April 14, 2026
Evaluation of the Proliferation Marker Ki-67 for Improved Risk Stratification of Prostate Cancer Patients Under Active Surveillance
Viktoria Schütz, Maresa Rothermel, Adam Kaczorowski, et al.
Scientific Reports
|
July 10, 2021
Detection of PD-L1 in the urine of patients with urothelial carcinoma of the bladder
Georgi Tosev, Wasilijiang Wahafu, Philipp Reimold, et al.
Scientific Reports
|
August 31, 2024
Digital spatial profiling identifies the tumor center as a topological niche in prostate cancer characterized by an upregulation of BAD
Ann-Kathrin Huber, Adam Kaczorowski, Felix Schneider, et al.
Scientific Reports
|
January 16, 2026
Prognostic impact of spatial niches in prostate cancer
Felix Schneider, Sarah Heike Böning, Beatriz Coelho Antunes, et al.
Urologic Oncology
|
July 9, 2024
Immune landscape of renal cell carcinoma with metastasis to the pancreas
Maximilian Kippenberger, Gita Schönberg, Adam Kaczorowski, et al.
Biomedicines
|
June 2, 2021
Targeting the Proteasome in Advanced Renal Cell Carcinoma: Complexity and Limitations of Patient-Individualized Preclinical Drug Discovery
Jielin Li, Laura Pohl, Julia Schüler, et al.
Cancers
|
October 28, 2023
Digital Spatial Profiling Identifies the Tumor Periphery as a Highly Active Biological Niche in Clear Cell Renal Cell Carcinoma
Felix Schneider, Adam Kaczorowski, Christina Jurcic, et al.
Frontiers in Oncology
|
June 20, 2025
Digital spatial profiling identifies phospho-JNK as a biomarker for early risk stratification of aggressive prostate cancer
Samaneh Eickelschulte, Adam Kaczorowski, Florian Janke, et al.
Urologic Oncology
|
June 12, 2018
FGF-2 is a driving force for chromosomal instability and a stromal factor associated with adverse clinico-pathological features in prostate cancer
Carine Pecqueux, Aysenur Arslan, Martina Heller, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 28) with videos related to
Sort By:
Page
of 3
Oncotarget
|
January 30, 2016
Delivery of improved oncolytic adenoviruses by mesenchymal stromal cells for elimination of tumorigenic pancreatic cancer cells
Adam Kaczorowski, Katharina Hammer, Li Liu, et al.
Diagnostics (Basel, Switzerland)
|
April 14, 2026
Evaluation of the Proliferation Marker Ki-67 for Improved Risk Stratification of Prostate Cancer Patients Under Active Surveillance
Viktoria Schütz, Maresa Rothermel, Adam Kaczorowski, et al.
Scientific Reports
|
July 10, 2021
Detection of PD-L1 in the urine of patients with urothelial carcinoma of the bladder
Georgi Tosev, Wasilijiang Wahafu, Philipp Reimold, et al.
Scientific Reports
|
August 31, 2024
Digital spatial profiling identifies the tumor center as a topological niche in prostate cancer characterized by an upregulation of BAD
Ann-Kathrin Huber, Adam Kaczorowski, Felix Schneider, et al.
Scientific Reports
|
January 16, 2026
Prognostic impact of spatial niches in prostate cancer
Felix Schneider, Sarah Heike Böning, Beatriz Coelho Antunes, et al.
Urologic Oncology
|
July 9, 2024
Immune landscape of renal cell carcinoma with metastasis to the pancreas
Maximilian Kippenberger, Gita Schönberg, Adam Kaczorowski, et al.
Biomedicines
|
June 2, 2021
Targeting the Proteasome in Advanced Renal Cell Carcinoma: Complexity and Limitations of Patient-Individualized Preclinical Drug Discovery
Jielin Li, Laura Pohl, Julia Schüler, et al.
Cancers
|
October 28, 2023
Digital Spatial Profiling Identifies the Tumor Periphery as a Highly Active Biological Niche in Clear Cell Renal Cell Carcinoma
Felix Schneider, Adam Kaczorowski, Christina Jurcic, et al.
Frontiers in Oncology
|
June 20, 2025
Digital spatial profiling identifies phospho-JNK as a biomarker for early risk stratification of aggressive prostate cancer
Samaneh Eickelschulte, Adam Kaczorowski, Florian Janke, et al.
Urologic Oncology
|
June 12, 2018
FGF-2 is a driving force for chromosomal instability and a stromal factor associated with adverse clinico-pathological features in prostate cancer
Carine Pecqueux, Aysenur Arslan, Martina Heller, et al.
Page
of 3